InvestorsHub Logo
Followers 20
Posts 5367
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Saturday, 06/04/2016 5:38:16 AM

Saturday, June 04, 2016 5:38:16 AM

Post# of 14941
Mallinckrodt is working on additional multi billion dollar markets for Acthar, including ALS indications. They are waiting on results of completed phase 2 trial to justify phase 3 trials.

Could bode well for ANI's Corti Drug franchise.

ALS indications
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News